StockTipsArenaBeta

BUY Akums Drugs and Pharmaceuticals — ICICI Securities

BUYAkums Drugs and Pharmaceuticals
Akums Drugs and Pharmaceuticals share price target & all analyst calls

byICICI SecuritiesHorizon: NA (inferred 1 year)4 Nov 2026via Institutional / Brokerage Research

Entry₹751.5Inferred
Target₹925
Total upside +23.09%
Stop lossNot given
CMP₹734.951d ago
Active-2.20%+25.86%upside left 12 mo left
Follow ICICI Securities for new calls(64% target hit, 1085 closed calls)Get alertsWatch AKUMS for new buy/sell callsGet alertsSee 3 other Long-term calls on AKUMSSee 541 other Long-term picks this week

Not investment advice; past performance doesn't guarantee future results. · Public beta — data is auto-extracted and may contain errors.

AI Assessment

Automated market context for this BUY call — facts from public sources, machine-classified. Not investment advice.

As of 7 Nov, 5:27 pm IST
16 supporting3 neutral0 opposing
Supports the BUY call (16)

Long-term trend bullish — 200-day average rising over the past quarter

Technicals · trend·6 Nov · yesterday

Akums Drugs and Pharmaceuticals reported strong Q2 FY27 results with revenue of ₹1,342 crore (up 31.9% YoY) and PAT of ₹115 crore (up 168% YoY). The company also acquired Oriflame India's manufacturin

NSE · Press Release·2 Nov · 4d ago

(opens in new tab)

Akums Drugs reported strong Q2 FY27 results with revenue of 1,342 crore (up 31.9% YoY), EBITDA of 195 crore (up 106% YoY), and PAT of 115 crore (up 168% YoY). It also acquired Oriflame India's manufac

BSE · Company Update·2 Nov · 4d ago

(opens in new tab)

The company reported unaudited standalone and consolidated financial results for the quarter and half-year ended September 30, 2026, showing growth in revenue and profit.

BSE · Board Meeting·2 Nov · 5d ago

(opens in new tab)

Akums Drugs and Pharmaceuticals reported standalone and consolidated financial results for the quarter and half-year ended September 30, 2026.

NSE · Outcome of Board Meeting·2 Nov · 5d ago

(opens in new tab)
Neutral / worth noting (3)

Nothing found in this tip’s window yet.

Weighs against the BUY call (0)

Nothing found in this tip’s window yet.

Factor classifications are AI-generated from exchange filings, verified news feeds and market data — they can be wrong or incomplete, and are not attributed to the issuing analyst. Verify every factor via its linked original before acting. This is not investment advice.

Other calls on Akums Drugs and Pharmaceuticals

All analyst calls on Akums Drugs and Pharmaceuticals

More from ICICI Securities

Every call and its outcome